GSK's Witty: We need to get drug pricing right

2:10 PM ET Tue, 13 Dec 2016

CNBC's Meg Tirrell speaks with Sir Andrew Witty, GlaxoSmithKline CEO, about the drugmaker's efforts in vaccine research and development at its new vaccine center in Maryland, as well as his views on pharmaceuticals and health care under President-elect Trump's administration.